Tech In Depth

Alibaba AI Takes Aim at Silent Liver Epidemic

Company’s model assesses medical screenings to find those in need of early diagnosis

An AI logo. Alibaba’s DAMO Academy has developed an AI model it hopes can help with early detection of fatty liver disease.Photographer: Krisztian Bocsi/Bloomberg

Provide news feedback or report an error

Confidential tip?

Send a tip to our reporters

Site feedback:

Take our Survey

By Saritha Rai

March 17, 2026 at 11:02 AM UTC

This article is for subscribers only.

Welcome to Tech In Depth, our daily newsletter about the business of tech from Bloomberg’s journalists around the world. Today, Saritha Rai looks at the promise of AI for medical diagnostics.

OpenAI reaches out to private equity: The AI company is in discussions with private equity firms, including Bain Capital, to form a joint venture valued at roughly $10 billion to bolster the adoption of artificial intelligence software.